Siga Technologies (SIGA) Net Cash Flow Growth (1y) (2011 - 2025)
Siga Technologies (SIGA) Net Cash Flow Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.15 Bn | 87.28 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.89 Bn | 32.15 Bn | 1.97 Bn | 112.26% |
| 3 | Zoetis | 32.49 Bn | 30.55 Bn | 1.62 Bn | -44.11% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.50 Bn | 4.39 Bn | 209.30% |
| 5 | United Therapeutics | 23.20 Bn | 21.05 Bn | 648.10 Mn | -236.85% |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn | 13,485.29% |
| 8 | Neurocrine Biosciences | 17.74 Bn | 16.43 Bn | 800.70 Mn | -1,047.81% |
| 9 | Elanco Animal Health | 12.58 Bn | 12.15 Bn | 785.00 Mn | -1,020.00% |
| 10 | Siga Technologies | 228.06 Mn | 73.10 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -36.82% |
| Jun 30, 2025 | 154.69% |
| Mar 31, 2025 | 209.46% |
| Dec 31, 2024 | -28.98% |
| Sep 30, 2024 | -50.61% |
| Jun 30, 2024 | 6.46% |
| Mar 31, 2024 | -137.17% |
| Dec 31, 2023 | 821.16% |
| Sep 30, 2023 | -6.65% |
| Jun 30, 2023 | -1.91% |
| Mar 31, 2023 | -66.30% |
| Dec 31, 2022 | -206.20% |
| Sep 30, 2022 | 15.62% |
| Jun 30, 2022 | -381.62% |
| Mar 31, 2022 | 541.10% |
| Dec 31, 2021 | -73.69% |
| Sep 30, 2021 | -122.14% |
| Jun 30, 2021 | 66.92% |
| Mar 31, 2021 | 86.41% |
| Dec 31, 2020 | 357.38% |